ENDO2025,Veligrotug,proptosis,diplopia,ThyroidEyeDisease

Mashup Score: 1

Veligrotug Safe, Efficacious for Active TED - 4 day(s) ago

Veligrotug demonstrated significant improvements in proptosis, diplopia, and clinical activity score among patients with active thyroid eye disease.

Source: www.endocrinologyadvisor.com

Categories: General Medicine News, Endocrinology

Tweet Tweets with this article
- EndoAdvisor
  
  From #ENDO2025: #Veligrotug vs placebo was associated with significant improvements in #proptosis, #diplopia, and clinical activity score in active #ThyroidEyeDisease. @TheEndoSociety @drzhangnunes @ThomasCiullaMD https://t.co/3kftH5uPB1